Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



KARBE FRANK Create: Alert

All | News | Filings
Date FiledTypeDescription
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/30/2023 4 KARBE FRANK (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $11.72, valued at $175.8k
09/15/2022 4 KARBE FRANK (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.
Txns: Bought 50,000 shares @ $2.0939, valued at $104.7k
07/07/2022 4 KARBE FRANK (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.
Txns: Granted 472,200 options to buy @ $1.68, valued at $793.3k
07/07/2022 3 KARBE FRANK (See Remarks) has filed a Form 3 on Better Therapeutics, Inc.
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2022 4 KARBE FRANK (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $13.61, valued at $272.2k
04/26/2022 3 KARBE FRANK (Director) has filed a Form 3 on Phathom Pharmaceuticals, Inc.
07/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 750 shares @ $21.4, valued at $16.1k
Exercised 750 options to buy @ $5.11, valued at $3.8k
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 750 shares @ $21.5, valued at $16.1k
Exercised 750 options to buy @ $5.11, valued at $3.8k
12/30/2020 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 11,800 shares @ $30, valued at $354k
Exercised 11,800 options to buy @ $5.11, valued at $60.3k
12/17/2020 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 380 shares @ $23.6321, valued at $9k
Sold 670 shares @ $24.4515, valued at $16.4k
Exercised 1,050 options to buy @ $5.11, valued at $5.4k
12/02/2020 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 1,500 shares @ $24, valued at $36k
Exercised 1,500 options to buy @ $5.11, valued at $7.7k
11/19/2020 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 750 shares @ $20, valued at $15k
Exercised 750 options to buy @ $5.11, valued at $3.8k
11/17/2020 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 750 shares @ $20, valued at $15k
Exercised 750 options to buy @ $5.11, valued at $3.8k
09/17/2020 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 750 shares @ $21.73, valued at $16.3k
Exercised 750 options to buy @ $5.11, valued at $3.8k
09/01/2020 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 3,650 shares @ $20.04, valued at $73.1k
Sold 21,150 shares @ $20.013, valued at $423.3k
Exercised 3,650 options to buy @ $5.11, valued at $18.7k
Exercised 21,150 options to buy @ $5.11, valued at $108.1k
08/21/2020 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 700 shares @ $20, valued at $14k
Exercised 700 options to buy @ $5.11, valued at $3.6k
05/28/2020 4 KARBE FRANK (Director) has filed a Form 4 on ADURO BIOTECH, INC.
Txns: Granted 30,000 options to buy @ $3, valued at $90k
04/07/2020 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 120,146 shares @ $0
Granted 183,991 options to buy @ $8.08, valued at $1.5M
12/30/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/27/2019 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 55,025 shares @ $0
Disposed/sold 200,000 options to buy @ $12.68, valued at $2.5M
Granted 200,000 options to buy @ $7.78, valued at $1.6M
Disposed/sold 114,690 options to buy @ $21.87, valued at $2.5M
Granted 114,690 options to buy @ $7.78, valued at $892.3k
Disposed/sold 132,270 options to buy @ $24.44, valued at $3.2M
Granted 132,270 options to buy @ $7.78, valued at $1M
06/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/15/2019 4 KARBE FRANK (Director) has filed a Form 4 on ADURO BIOTECH, INC.
Txns: Granted 30,000 options to buy @ $3.29, valued at $98.7k
05/08/2019 3/A KARBE FRANK (Director) has filed a Form 3/A on ADURO BIOTECH, INC.
04/19/2019 4 KARBE FRANK (Director) has filed a Form 4 on ADURO BIOTECH, INC.
Txns: Granted 60,000 options to buy @ $3.38, valued at $202.8k
04/19/2019 3 KARBE FRANK (Director) has filed a Form 3 on ADURO BIOTECH, INC.
04/09/2019 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 132,270 options to buy @ $24.44, valued at $3.2M
04/18/2018 4 KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 114,690 options to buy @ $21.87, valued at $2.5M
06/23/2017 4 KARBE FRANK (Director) has filed a Form 4 on Arbutus Biopharma Corp
Txns: Granted 22,000 options to buy @ $3.55, valued at $78.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy